Irbesartan hydrochlorothiazide by Viatris is a generic version of Coaprovel. Coaprovel is a combination medication containing irbesartan and hydrochlorothiazide. Viatris manufactures this generic equivalent [1].
When does Coaprovel's patent protection end?
Patent protection for Coaprovel, and by extension its generic versions, is determined by patent expiry dates. Information on specific patent statuses and their expiry can be found on resources like DrugPatentWatch.com [2].
What are the active ingredients in Coaprovel and its generic versions?
Coaprovel and its generic counterpart, irbesartan hydrochlorothiazide Viatris, both contain two active pharmaceutical ingredients: irbesartan and hydrochlorothiazide [1]. Irbesartan belongs to a class of drugs called angiotensin II receptor blockers (ARBs), while hydrochlorothiazide is a thiazide diuretic.
How do generic drugs like Viatris' irbesartan hydrochlorothiazide differ from the brand-name Coaprovel?
Generic drugs are required to be bioequivalent to their brand-name counterparts, meaning they contain the same active ingredients in the same dosage and are absorbed into the bloodstream at roughly the same rate [3]. The primary differences typically lie in inactive ingredients, such as fillers or dyes, and in branding and pricing. Viatris produces this generic version, making it available as a lower-cost alternative to Coaprovel [1].
What is the typical use for medications like Coaprovel?
Medications combining irbesartan and hydrochlorothiazide are used to treat high blood pressure (hypertension). Irbesartan works by blocking the action of angiotensin II, a substance in the body that narrows blood vessels, thereby lowering blood pressure. Hydrochlorothiazide helps the body eliminate excess salt and water, further reducing blood pressure [1].
Are there other generic manufacturers of irbesartan hydrochlorothiazide?
While Viatris is a manufacturer of the generic irbesartan hydrochlorothiazide, other pharmaceutical companies may also produce generic versions of this combination drug once patent protections expire and regulatory approvals are obtained [2].
What is the regulatory process for approving generic drugs?
Before a generic drug like irbesartan hydrochlorothiazide Viatris can be marketed, it must receive approval from regulatory agencies, such as the U.S. Food and Drug Administration (FDA). This approval process ensures that the generic drug meets the same quality, safety, and efficacy standards as the brand-name drug [3].
What is the cost difference between Coaprovel and its generic equivalents?
Generic medications are generally less expensive than their brand-name counterparts. This cost difference is a key factor for patients and healthcare systems when choosing between brand-name drugs like Coaprovel and generics such as irbesartan hydrochlorothiazide by Viatris [1].
---
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.fda.gov/